3 ms·
That's not the point. The point is: at 19 USD per share you nearly buy at a valuation (8 billion) at which the institutional investors bought Ancestry ($4.7 bi
by Wronnay 6y ago
That's not the point.
The point is: at 19 USD per share you nearly buy at a valuation (8 billion) at which the institutional investors bought Ancestry ($4.7 billion) and 23andMe ($3.5 billion)
Also: 23andMe had declining revenue in the past years and does only make around 200 million revenue.
You buy a business at a valuation at 8 billion which makes only around 200 million revenue.
- trott 6y agoIt's a good point. I'm just saying that this coming tech revolution is another issue to consider.
- bagacrap 6y agoI'm assuming they're going to try to start monetizing the data they've collected, not that they expect people to keep paying for more and more tests. I wouldn't read too much into the revenue that the old model generated. (People complain that Facebook etc have become big and powerful by sucking up all your data, but at least Zuck didn't charge you for the data.)